No Data
Fangsheng Pharmaceutical's Xiao'er Jingxing Zhike Granules Show Positive Results in Clinical Trial Report
Fangsheng Pharmaceutical: Hunan Nansheng Pharmaceutical Co., Ltd. 2024 Annual Report
Fangsheng Pharmaceutical: Hunan Nansheng Pharmaceutical Co., Ltd. Report for the first quarter of 2025
Fangsheng Pharmaceutical: Summary of Fangsheng Pharmaceutical\'s 2024 Annual Report
Hunan Fangsheng Pharmaceutical Co., Ltd. 2024 Annual Report
Summary of Fangsheng Pharmaceutical\'s 2024 Annual Report
Investors Don't See Light At End Of Hunan Fangsheng Pharmaceutical Co., Ltd.'s (SHSE:603998) Tunnel And Push Stock Down 29%